Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: AMD1, a cardiotoxicity target for Maduramicin

Fig. 3

Maduramicin myocardial injury in H9c2 cells. (a)&(b) AMD1 protein expression with three kinds of siRNA-AMD1. ***P < 0.001, ****P < 0.0001. (c) Flow cytometry to observe H9c2 cell apoptosis in control, Mad treatment and Mad treatment with siRNA-AMD1 transfection. (d)&(e) The protein expression of AMD1 with Western blotting. ***P < 0.001, ****P < 0.0001. (f)&(g) The protein expression of Caspase-3 with Western blotting. ***P < 0.001

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us